Kevin Mcelwee, Chief Scientific Officer at RepliCel Life Sciences, holds 3.66M shares in RepliCel Life Sciences (Ticker: REPCF). Most recently, Kevin Mcelwee Bought $670,833 shares of RepliCel Life Sciences on Jan 19, 2023 for an estimated value of 60.37K.